Advertisement

The Effect of Dexamethasone on the Neurotoxicity of Nitroimidazole Compounds

  • R. C. Urtasun
  • H. Tanasichuk
  • J. Partington
  • D. Koziol
  • J. Allalunis
  • R. Turner
Part of the NATO Advanced Study Institutes Series book series (NSSA, volume 43)

Abstract

A total of 300 patients have been entered in our Institution to receive either Misonidazole or Metronidazole in order to study the usefulness of these compounds as hypoxic cell sensitizers. The present report deals with our attempts to reduce the toxicity of these drugs.

Acute GI toxicity, although present in 30–40% of our patients tpending on the total dose and type of drug), has not been our dose limiting factor. On the other hand, peripheral neuropathies have been the major obstacle in reaching blood and tumour tissue drug therapeutic levels.

Consequently we have explored the possible protective effect of Dexamethasone against the neurotoxicity of Misonidazole. A preliminary analysis of our presently ongoing prospective study is suggestive that Dexamethasone may exert a protective effect, although we have found that unlike Phenytoin it does not appear to alter the kinetics of Misonidazole in blood.

Keywords

Peripheral Neuropathy Maximum Tolerable Dose Sensory Peripheral Neuropathy High Performance Liquid Chromatography Assay Ongoing Prospective Study 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    R. C. Urtasun, J. Sturmwind, H. Rabin, P. R. Band, and J. D. Chapman, High dose Metronidazole: a preliminary pharmacological study prior to its investigational use in clinical radiotherapy trials, Brit. J. Radiol. 47:293 (1974).CrossRefGoogle Scholar
  2. 2.
    R. C. Urtasun, J. D. Chapman, P. Band, H. Rabin, C. Fryer, and J. Sturmwind, Phase I study of high dose Metronidazole, an in vivo and in vitro specific radiosensitizer of hypoxic cells, Radiology 111:129 61975).Google Scholar
  3. 3.
    R. C. Urtasun, P. Band, J. D. Chapman, A. F. Wilson, B. Marynowski, and E. Starreveld, Misonidazole neurotoxicity, New Engl. J. Med. 295:901 (1976).CrossRefGoogle Scholar
  4. 4.
    R. C. Urtasun, J. D. Chapman, M. L. Feldstein, P. R. Band, H. R. Rabin, A. F. Wilson, B. Marynowski, E. Starreveld, and T. Shnitka, Peripheral neuropathy related to misonidazole: incidence and pathology, Br. J. Cancer 37: Suppl.III:271 (1978).Google Scholar
  5. 5.
    T. H. Wasserman, T. L. Phillips, R. J. Johnson, C. J. Gomer, A. G. Lawrence, W. Sadee, R. A. Marques, V. A. Levin, and G. VanRaalte, Initial clinical and pharmacologic evaluation of misonidazole (Ro-07–0582), a hypoxic cell radiosensitizer, Int. J. Radiat. Oncol. Biol. Phys. 5:775 (1979).PubMedCrossRefGoogle Scholar
  6. 6.
    J. M. Allalunis, R. A. Turner, J. P. Partington, and R. C. Urtasun, Effect of Misonidazole therapy on human granulopoietic stem cells, Cancer Treatment Reports 64:1097 (1980).PubMedGoogle Scholar
  7. 7.
    B. J. W. Arnason, and E. Chemilcka-Szorc, Peripheral nerve segmental demyelination induced by intraneural diphtheria toxin injection and the effect of hydrocortisone, Arch. Neurol. 30:157 (1974).PubMedCrossRefGoogle Scholar
  8. 8.
    S. Dische, M. I. Saunders, et al., Clinical testing of the radiosensitizer Ro-07–0582 — experience with multiple doses, Br. J. Cancer 35:567 (1977).PubMedCrossRefGoogle Scholar
  9. 9.
    S. Dische, M. I. Saunders, P. Anderson, R. C. Urtasun, K. H. Karcher, H. D. Kogelnik, T. Phillips and T. H. Wasserman, The neurotoxicity of misonidazole: pooling of data from five centers, Brit. J. Radiol. 51:Lo23 (1978).CrossRefGoogle Scholar
  10. 10.
    V. A. Levin, E. Chemilcka-Szorc, and B. J. W. Arnason, Peripheral nerve segmental demyelination induced by intraneural diphtheria toxin injection and the effect of hydrocortisone, Arch. Neurol. 30:163 (1974).Google Scholar
  11. 11.
    R. A. Turner, J. Allalunis, R. C. Urtasun et al., Cytotoxic and radiosensitizing effects of Misonidazole on haematopoiesis in snormal and tumor-bearing mice, Int. J. Rad, Onc. 6: 1157 (1980).CrossRefGoogle Scholar
  12. 12.
    T. H. Wasserman, T. L. Phillips, G. VanRaalte, R. C. Urtasun, J. Partington, D. Koziol, J. G. Schwade, D. Gangji, and J. M. Strong, The neurotoxicity of misonidazole: potential modifying role of Phenytoin sodium and dexamethasone, Brit. J. Radiol. 53:170 (1980).CrossRefGoogle Scholar
  13. 13.
    C. R. Wiltshire, P. Workmsn, J. V. Watson, and N. M. Bleehen, Clinical studies with Misonidazole, Br. J. Cancer 37: Suppl.III:286 (1978).Google Scholar
  14. 14.
    P. Workman, Drug interactions with misonidazole: effects of dexamethasone and its derivatives on the pharmacokinetics and toxicity of misonidazole in mice, Biochem. Pharmacol. (1981) in press.Google Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • R. C. Urtasun
    • 1
  • H. Tanasichuk
    • 1
  • J. Partington
    • 1
  • D. Koziol
    • 1
  • J. Allalunis
    • 1
  • R. Turner
    • 1
  1. 1.Departments of Radiation and Medical Oncology, Cross Cancer InstituteUniversity of AlbertaEdmontonCanada

Personalised recommendations